Product Information
MOEXIPRIL HCL 15 MG TABLET is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.9994 per EA under NDC 68462020801. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
15 mg/1
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462020801
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
MOEXIPRIL HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA090416On Market Since
12/31/2010
Pharmacological Classes
Price Statistics
The NADAC for MOEXIPRIL HCL 15 MG TABLET has been published 657 times since Nov 28, 2013, and over the history we have for it it has risen 98.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9994 per EA |
|---|---|
| All-time high | $1.0045 (Mar 11, 2026) |
| All-time low | $0.5048 (Nov 28, 2013) |
| 52-week high | $1.0045 |
| 52-week low | $0.9358 |
| Median price | $0.8110 |
| Average price | $0.8070 |
| Largest weekly change | +37.0% (Mar 18, 2020) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of MOEXIPRIL HCL 15 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MOEXIPRIL HCL 15 MG TABLET, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.9994 per EA (NDC 68462020801), effective Jun 24, 2026.
How has the price of MOEXIPRIL HCL 15 MG TABLET changed over time?
Over the history we have for it, the NADAC for MOEXIPRIL HCL 15 MG TABLET has risen 98.0%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for MOEXIPRIL HCL 15 MG TABLET?
Since Nov 28, 2013, the NADAC for MOEXIPRIL HCL 15 MG TABLET has ranged from a low of $0.5048 (Nov 28, 2013) to a high of $1.0045 (Mar 11, 2026), with a median of $0.8110 per EA.
Are there cheaper alternatives to MOEXIPRIL HCL 15 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as MOEXIPRIL HCL 15 MG TABLET, but none are currently priced below it.
Who manufactures MOEXIPRIL HCL 15 MG TABLET?
MOEXIPRIL HCL 15 MG TABLET (NDC 68462020801) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.
Related Drugs
Same classification